EDNRA and prostate cancer: Using prostate cancer tissue as a positive control (Figure 1A) [31], ETAR expression was present in 73.9% (113/153) of the tumor samples, whereas 14 cases (14/18, 77.8%) of normal nasopharyngeal tissues were negative for ETAR expression (Figure 1B).